Nasus Pharma Ltd. (NSRX)

NYSEAMERICAN: NSRX · Real-Time Price · USD

4.000

+0.150 (3.90%)

Aug 21, 2026, 4:00 PM EDT - Market closed

Nasus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	7.82	1.24	0.28	0.19	0.15
Short-Term Investments	4	3.05	-	-	-
Cash & Short-Term Investments	11.82	4.29	0.28	0.19	0.15
Cash Growth	5721.68%	1409.15%	47.15%	25.32%	-
Prepaid Expenses	0.41	0.33	0.12	0.23	0.25
Restricted Cash	0.09	0.05	0.03	0.02	0.02
Other Current Assets	-	0.19	0.03	-	-
Total Current Assets	12.31	4.86	0.46	0.44	0.42
Property, Plant & Equipment	0.14	0.15	-	-	-
Long-Term Deferred Charges	-	-	0.26	-	-
Total Assets	12.45	5	0.72	0.44	0.42

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	0.35	0.83	0.65	0.66	0.77
Accrued Expenses	0.57	0.79	0.88	0.62	0.35
Short-Term Debt	-	-	1.8	2.46	1.57
Current Portion of Leases	0.05	0.05	-	-	-
Other Current Liabilities	0.44	0.5	0.6	0.51	0.51
Total Current Liabilities	1.4	2.16	3.93	4.24	3.2
Long-Term Leases	0.05	0.07	-	-	-
Total Liabilities	1.45	2.24	3.93	4.24	3.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	-	-	0.02	0.02	0
Additional Paid-In Capital	35.46	21.29	9.43	7.32	7.29
Retained Earnings	-24.46	-18.52	-12.66	-11.13	-10.08
Shareholders' Equity	11	2.77	-3.21	-3.8	-2.79
Total Liabilities & Equity	12.45	5	0.72	0.44	0.42

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	0.1	0.12	1.8	2.46	1.57
Net Cash (Debt)	11.72	4.17	-1.52	-2.26	-1.42
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	1.19	0.52	-0.22	-0.32	-0.21
Filing Date Shares Outstanding	11.71	11.71	7.36	6.89	6.89
Total Common Shares Outstanding	11.71	9.02	7.36	6.89	6.89
Working Capital	10.91	2.69	-3.47	-3.8	-2.79
Book Value Per Share	0.94	0.31	-0.44	-0.55	-0.40
Tangible Book Value	11	2.77	-3.21	-3.8	-2.79
Tangible Book Value Per Share	0.94	0.31	-0.44	-0.55	-0.40

SEC Filings: 10-K · 10-Q